To: | The Prolmmune Company, L.L.C. (tmde@ratnerprestia.com) |
Subject: | U.S. Trademark Application Serial No. 90115305 - PROTHIONE CAPSULES - PIM-121US |
Sent: | September 20, 2021 11:45:32 AM |
Sent As: | ecom111@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 90115305
Mark: PROTHIONE CAPSULES
|
|
Correspondence Address: |
|
Applicant: The Prolmmune Company, L.L.C.
|
|
Reference/Docket No. PIM-121US
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: September 20, 2021
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. The examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the goods and/or services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and/or services are not permitted. 37 C.F.R. §2.71(a).
Applicant is The Proimmune Company, L.L.C., a limited liability company of Delaware.
/James Ringle/
Trademark Attorney
United States Patent and Trademark Office
Law Office 111
571-272-9393
jim.ringle@uspto.gov